Skip to content
GOODS ACROSS BORDERS

ITEM RULE · TRAVELING

RESTRICTED

Vyvanse / Lisdexamfetamine 🇬🇧 United Kingdom

VERIFIED · 2026-04-25MEDIUM CONFIDENCE

Vyvanse / Lisdexamfetamine restricted; documentation or permits may apply

ANSWER

Can I bring Vyvanse / Lisdexamfetamine into United Kingdom?

RESTRICTEDVERIFIED · 2026-04-25MEDIUM CONFIDENCE

Vyvanse / Lisdexamfetamine restricted; documentation or permits may apply

QUANTITY / LIMITS

Up to 3 months under Home Office personal licence exemption (Schedule 2 CD)

DOCUMENTS

  • Home Office personal import/export licence (required for Schedule 2 controlled drug over 3 months)
  • Original prescription from licensed physician
  • Medication in original pharmacy-labelled packaging

DECLARATION

Required at the destination customs authority

SOURCE

gov.uk
Verify against the official customs authority before acting on this answer.Report a correction

Full details

Lisdexamfetamine (Vyvanse/Elvanse) is classified as an amphetamine derivative and is prohibited in Japan regardless of prescription status — no import permit pathway exists for personal use. China, South Korea, and most of Southeast Asia prohibit or severely restrict amphetamine-based ADHD medicatio

PRACTICAL ADVICE

Carry documentation. Declare at customs if required.

OFFICIAL SOURCES · VERIFIED 2026-04-25

RULE DETAILS

QUANTITY LIMITS

Up to 3 months under Home Office personal licence exemption (Schedule 2 CD)

DOCUMENTATION REQUIRED

  • Home Office personal import/export licence (required for Schedule 2 controlled drug over 3 months)
  • Original prescription from licensed physician
  • Medication in original pharmacy-labelled packaging

AIR TRAVEL IS SEPARATE

This page covers destination customs rules in United Kingdom. Whether you can carry vyvanse / lisdexamfetamine through security, in carry-on, or in checked baggage depends on airline and screening rules — see air travel rules.

Related rules

Vyvanse / Lisdexamfetamine rules in other countries

RULES5,339COUNTRIES85ITEMS111CARRIERS28GUIDES37UNIQUE SOURCES614LATEST VERIFICATION2026-05-13MethodologyChangelog